Fortrea Holdings FTRE
NASDAQ FTRE
$18.16 -0.46 (-2.47%)
As of: Sep 4, 2026 · 1:30 PM EDT

Fortrea Holdings (FTRE) Sales of Property, Plant and Equipment (2022 - 2024)

Analysis

Fortrea Holdings (FTRE) Sales of Property, Plant and Equipment (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn -
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn -
10 Fortrea Holdings 1.72 Bn 1.55 Bn 139.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 300,000.00
Sep 30, 2024 100,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 7.80 Mn
Jun 30, 2023 300,000.00
Sep 30, 2022 100,000.00